Childhood cancers trials in China

In China 609 Also abroad 2483

609 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Tamsulosin for Early Catheter Removal After Rectal Cancer Surgery
Where
Changchun, Harbin
People
1,545
Run by
The First Hospital of Jilin University
See details and how to joinNCT07346586
No phaseNot yet taking people in China
TACE in Combination With Tislelizumab and Lenvatinib for Advanced HCC (CHANCE2602)
Where
Nanjing
Age
16 years and over
People
596
Run by
Zhongda Hospital
See details and how to joinNCT07836309
Phase 2Taking people
A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer
Where
Shanghai
People
20
Run by
Fudan University
See details and how to joinNCT07497919
Phase 2/3Taking people
Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma
Where
Beijing
People
80
Run by
Chinese PLA General Hospital
See details and how to joinNCT02851784
No phaseTaking people
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
Where
Beijing
People
2,000
Run by
Peking University First Hospital
See details and how to joinNCT05283993
Phase 3Taking people
Study of XNW28012 in Subjects With Metastatic Pancreatic Cancer Who Received Prior Systemic Therapy
Where
Beijing, Binzhou, Changsha, Changzhou, Chengdu, Chongqing, Fuyang, Fuzhou, Guangzhou, Ha’erbin, Hangzhou, Hefei, Jilin City, Jinan, Lanzhou, Meizhou, Nanchang, Nanjing, Nanning, Neimeng, Ningbo, Shanghai, Shenyang, Taiyuan, Tianjin, Wuhan, Xiamen, Xi'an, Xiangyang, Yangzhou, Yinchuan, Zhengzhou
People
226
Run by
Evopoint Biosciences Inc.
See details and how to joinNCT07823049
Phase 2Taking people
A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents
Where
Beijing, Changsha, Chengdu, Chongqing, Hangzhou, Henan, Nanchang, Nanjing, Shenzhen, Suzhou, Tianjin, Wuhan
Age
3 years to 21 years
People
100
Run by
Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT05334823
No phaseTaking people
Laparoscopic-endoscopic Surgery Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric Cancer
Where
Ch’ang-ch’un, Changchun
People
36
Run by
Jilin University
See details and how to joinNCT07615374
Phase 3Taking people
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Where
Beijing, Shanghai
Age
12 years to 100 years
People
240 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00
Phase 1/2Taking people
CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas
Where
Beijing, Shanghai
Age
14 years to 70 years
People
36
Run by
Beijing GoBroad Hospital
See details and how to joinNCT07022964
Phase 2Not yet taking people in China
Pirtobrutinib Plus Methotrexate-Based Chemoimmunotherapy for Systemic DLBCL With CNS Involvement
Where
Shanghai
Age
14 years to 80 years
People
24
Run by
Pengpeng Xu
See details and how to joinNCT07812493
No phaseTaking people
Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival
Where
Hangzhou
Age
1 month to 18 years
People
500
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07813208
No phaseTaking people
Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces
Where
Changsha
People
500
Run by
Central South University
See details and how to joinNCT07066813
Phase 1/2Taking people
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Where
Baoding, Bengbu, Chongqing, Guangzhou, Hangzhou, Hefei, Linyi, Nanchang, Shenyang, Suzhou, Tianjin, Zhengzhou
Age
12 years and over
People
160 worldwide
Run by
Sellas Life Sciences Group
See details and how to joinNCT04588922
No phaseTaking people
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
Where
Suzhou
People
43
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT05772273
No phaseTaking people
Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)
Where
Hangzhou
Age
12 years to 60 years
People
138
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07183878
Phase 1Taking people
U69-CART-Cells For R/R T-ALL
Where
Suzhou
Age
15 years to 75 years
People
12
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07350863
No phaseTaking people
ET-SPACE Whole-Body Infrared Hyperthermia in Patients With Advanced Solid Tumors
Where
Hangzhou
People
500
Run by
Zhejiang Hospital
See details and how to joinNCT07793214
Phase 1Taking people
Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL
Where
Hefei, Jinan, Shanghai, Tianjin
Age
1 year to 18 years
People
19
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT05495035
Phase 1Enrolling by invitation
A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies
Where
Tianjin
Age
3 years to 70 years
People
13
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07784309
Phase 1/2Taking people
APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors
Where
Guangzhou, Tianjin, Wuhan
Age
5 years and over
People
100
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT05701306
No phaseTaking people
Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
Where
Beijing
Age
Up to 45 years
People
16
Run by
Peking University People's Hospital
See details and how to joinNCT06468215
Early phase 1Taking people
Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma
Where
Chengdu
Age
1 year to 100 years
People
10
Run by
Sichuan University
See details and how to joinNCT07767630
No phaseTaking people
Safety and Efficacy of Cryoablation for Thyroid Tumors
Where
Beijing
People
108
Run by
Yukun Luo
See details and how to joinNCT07776262
Early phase 1Taking people
68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma
Where
Beijing
Age
10 years to 80 years
People
16
Run by
Peking University First Hospital
See details and how to joinNCT07774533